Mer­ck and PhRMA to FDA: Wait for ICH be­fore fi­nal­iz­ing guid­ance on tox­i­c­i­ty test­ing for can­cer drugs

Drug­mak­ers and in­dus­try groups are call­ing on the FDA to hold off on fi­nal­iz­ing a draft guid­ance un­til the In­ter­na­tion­al Coun­cil on Har­mon­i­sa­tion (ICH) fi­nal­izes …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER